Bayesian Capital Management LP Buys Shares of 9,600 Adient plc (NYSE:ADNT)

Bayesian Capital Management LP bought a new stake in Adient plc (NYSE:ADNT) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 9,600 shares of the company’s stock, valued at approximately $316,000.

A number of other large investors have also recently modified their holdings of the business. Dimensional Fund Advisors LP boosted its holdings in shares of Adient by 4.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,017,402 shares of the company’s stock valued at $182,434,000 after purchasing an additional 196,857 shares in the last quarter. Hotchkis & Wiley Capital Management LLC lifted its stake in shares of Adient by 5.4% in the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 4,469,049 shares of the company’s stock valued at $162,495,000 after acquiring an additional 229,963 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of Adient by 1.2% in the 4th quarter. Franklin Resources Inc. now owns 3,233,171 shares of the company’s stock valued at $117,558,000 after acquiring an additional 37,010 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Adient by 9.9% in the 4th quarter. Vanguard Group Inc. now owns 2,732,345 shares of the company’s stock valued at $99,348,000 after acquiring an additional 246,038 shares during the last quarter. Finally, Pzena Investment Management LLC lifted its stake in shares of Adient by 8.9% in the 1st quarter. Pzena Investment Management LLC now owns 1,978,961 shares of the company’s stock valued at $65,147,000 after acquiring an additional 161,579 shares during the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.

Adient Stock Performance

ADNT stock opened at $25.78 on Thursday. The stock has a 50-day moving average price of $25.74 and a 200-day moving average price of $29.93. Adient plc has a 1-year low of $22.93 and a 1-year high of $46.51. The company has a current ratio of 1.13, a quick ratio of 0.91 and a debt-to-equity ratio of 1.00. The firm has a market cap of $2.32 billion, a PE ratio of 15.82, a price-to-earnings-growth ratio of 0.46 and a beta of 2.19.

Adient (NYSE:ADNT) last posted its quarterly earnings data on Friday, May 3rd. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.15. Adient had a return on equity of 8.72% and a net margin of 1.04%. The firm had revenue of $3.75 billion during the quarter, compared to analyst estimates of $3.80 billion. During the same period last year, the company posted $0.32 EPS. The business’s quarterly revenue was down 4.1% on a year-over-year basis. As a group, equities research analysts expect that Adient plc will post 2.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

ADNT has been the subject of a number of research reports. Bank of America dropped their price target on Adient from $42.00 to $40.00 and set a “buy” rating for the company in a research note on Monday, July 22nd. UBS Group dropped their price target on Adient from $31.00 to $27.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. JPMorgan Chase & Co. dropped their price target on Adient from $32.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Morgan Stanley dropped their price target on Adient from $35.00 to $32.00 and set an “underweight” rating for the company in a research note on Friday, May 10th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Adient from $32.00 to $30.00 and set a “hold” rating for the company in a research report on Monday, May 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Adient currently has a consensus rating of “Hold” and an average target price of $34.33.

Insider Transactions at Adient

In other news, Director Peter Carlin sold 4,207 shares of Adient stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $28.90, for a total value of $121,582.30. Following the completion of the transaction, the director now directly owns 28,352 shares of the company’s stock, valued at approximately $819,372.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

About Adient

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.